000 01586 a2200457 4500
005 20250515214117.0
264 0 _c20100611
008 201006s 0 0 eng d
022 _a1470-8752
024 7 _a10.1042/BST0380552
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHands, Sarah L
245 0 0 _aMetallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.
_h[electronic resource]
260 _bBiochemical Society transactions
_cApr 2010
300 _a552-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCarrier Proteins
_xgenetics
650 0 4 _aCopper
_xmetabolism
650 0 4 _aDrug Delivery Systems
650 0 4 _aExons
_xgenetics
650 0 4 _aGene Targeting
650 0 4 _aHeLa Cells
650 0 4 _aHomeostasis
_xgenetics
650 0 4 _aHumans
650 0 4 _aHuntingtin Protein
650 0 4 _aHuntington Disease
_xgenetics
650 0 4 _aMetabolic Networks and Pathways
_xgenetics
650 0 4 _aMetallothionein
_xmetabolism
650 0 4 _aMutant Proteins
_xgenetics
650 0 4 _aNerve Tissue Proteins
_xgenetics
650 0 4 _aNuclear Proteins
_xgenetics
650 0 4 _aProtein Binding
_xgenetics
650 0 4 _aSaccharomyces
650 0 4 _aTransfection
700 1 _aMason, Robert
700 1 _aSajjad, M Umar
700 1 _aGiorgini, Flaviano
700 1 _aWyttenbach, Andreas
773 0 _tBiochemical Society transactions
_gvol. 38
_gno. 2
_gp. 552-8
856 4 0 _uhttps://doi.org/10.1042/BST0380552
_zAvailable from publisher's website
999 _c19662686
_d19662686